S&P 500   3,244.16 (-0.07%)
DOW   26,790.82 (-0.09%)
QQQ   265.29 (-0.04%)
AAPL   108.11 (-0.10%)
MSFT   203.42 (+0.11%)
FB   248.05 (-0.59%)
GOOGL   1,418.96 (-0.27%)
AMZN   3,031.46 (+0.39%)
TSLA   397.19 (+2.42%)
NVDA   493.75 (-0.03%)
BABA   265.84 (-1.44%)
CGC   14.29 (+0.14%)
GE   6.09 (+0.50%)
MU   48.86 (-1.23%)
AMD   75.57 (-0.33%)
T   27.96 (-0.29%)
F   6.65 (-0.15%)
ACB   5.25 (+0.96%)
GILD   62.31 (+0.10%)
NFLX   472.16 (-0.19%)
DIS   121.20 (-1.05%)
BAC   23.29 (-0.21%)
BA   148.29 (+1.53%)
S&P 500   3,244.16 (-0.07%)
DOW   26,790.82 (-0.09%)
QQQ   265.29 (-0.04%)
AAPL   108.11 (-0.10%)
MSFT   203.42 (+0.11%)
FB   248.05 (-0.59%)
GOOGL   1,418.96 (-0.27%)
AMZN   3,031.46 (+0.39%)
TSLA   397.19 (+2.42%)
NVDA   493.75 (-0.03%)
BABA   265.84 (-1.44%)
CGC   14.29 (+0.14%)
GE   6.09 (+0.50%)
MU   48.86 (-1.23%)
AMD   75.57 (-0.33%)
T   27.96 (-0.29%)
F   6.65 (-0.15%)
ACB   5.25 (+0.96%)
GILD   62.31 (+0.10%)
NFLX   472.16 (-0.19%)
DIS   121.20 (-1.05%)
BAC   23.29 (-0.21%)
BA   148.29 (+1.53%)
S&P 500   3,244.16 (-0.07%)
DOW   26,790.82 (-0.09%)
QQQ   265.29 (-0.04%)
AAPL   108.11 (-0.10%)
MSFT   203.42 (+0.11%)
FB   248.05 (-0.59%)
GOOGL   1,418.96 (-0.27%)
AMZN   3,031.46 (+0.39%)
TSLA   397.19 (+2.42%)
NVDA   493.75 (-0.03%)
BABA   265.84 (-1.44%)
CGC   14.29 (+0.14%)
GE   6.09 (+0.50%)
MU   48.86 (-1.23%)
AMD   75.57 (-0.33%)
T   27.96 (-0.29%)
F   6.65 (-0.15%)
ACB   5.25 (+0.96%)
GILD   62.31 (+0.10%)
NFLX   472.16 (-0.19%)
DIS   121.20 (-1.05%)
BAC   23.29 (-0.21%)
BA   148.29 (+1.53%)
S&P 500   3,244.16 (-0.07%)
DOW   26,790.82 (-0.09%)
QQQ   265.29 (-0.04%)
AAPL   108.11 (-0.10%)
MSFT   203.42 (+0.11%)
FB   248.05 (-0.59%)
GOOGL   1,418.96 (-0.27%)
AMZN   3,031.46 (+0.39%)
TSLA   397.19 (+2.42%)
NVDA   493.75 (-0.03%)
BABA   265.84 (-1.44%)
CGC   14.29 (+0.14%)
GE   6.09 (+0.50%)
MU   48.86 (-1.23%)
AMD   75.57 (-0.33%)
T   27.96 (-0.29%)
F   6.65 (-0.15%)
ACB   5.25 (+0.96%)
GILD   62.31 (+0.10%)
NFLX   472.16 (-0.19%)
DIS   121.20 (-1.05%)
BAC   23.29 (-0.21%)
BA   148.29 (+1.53%)
Log in
NASDAQ:ITMR

Itamar Medical Stock Forecast, Price & News

$21.18
-0.45 (-2.08 %)
(As of 09/24/2020 12:00 AM ET)
Add
Compare
Today's Range
$20.47
Now: $21.18
$21.28
50-Day Range
$19.05
MA: $22.11
$25.96
52-Week Range
$7.66
Now: $21.18
$29.00
Volume10,522 shs
Average Volume30,649 shs
Market Capitalization$236.71 million
P/E RatioN/A
Dividend YieldN/A
Beta1.53
Itamar Medical Ltd. engages in the research, development, marketing, sale, and leasing of non-invasive medical devices for the cardiology market. The company offers medical devices based on Peripheral Arterial Tone (PAT) signal, which measures changes in the patient's peripheral arterial pulse volumes and various parameters of arterial activities. It provides WatchPAT device, which enables home sleep tests for various sleeping disorders, including obstructive sleep apnea; and Endo PAT device that diagnoses endothelial dysfunction. The company operates in the United States, Canada, Europe, Israel, Japan, the Asia Pacific, and other countries. Itamar Medical Ltd. has a collaboration agreement with SoClean Inc. to offer WatchPAT ONE home sleep apnea test and digital health services through direct-to-consumer channels. The company was formerly known as Itamar Medical (CM) 1997 Ltd. and changed its name to Itamar Medical Ltd. in July 2000. Itamar Medical Ltd. was founded in 1997 and is headquartered in Caesarea, Israel.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.33 out of 5 stars


Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:ITMR
CUSIPN/A
CIKN/A
WebN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$31.26 million

Profitability

Miscellaneous

Employees184
Market Cap$236.71 million
Next Earnings Date11/24/2020 (Estimated)
OptionableNot Optionable
$21.18
-0.45 (-2.08 %)
(As of 09/24/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ITMR News and Ratings via Email

Sign-up to receive the latest news and ratings for ITMR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Itamar Medical (NASDAQ:ITMR) Frequently Asked Questions

How has Itamar Medical's stock been impacted by COVID-19 (Coronavirus)?

Itamar Medical's stock was trading at $11.11 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ITMR shares have increased by 90.6% and is now trading at $21.18.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Itamar Medical?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Itamar Medical in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Itamar Medical
.

When is Itamar Medical's next earnings date?

Itamar Medical is scheduled to release its next quarterly earnings announcement on Tuesday, November 24th 2020.
View our earnings forecast for Itamar Medical
.

How were Itamar Medical's earnings last quarter?

Itamar Medical Ltd. (NASDAQ:ITMR) posted its earnings results on Tuesday, August, 11th. The company reported ($0.22) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.21) by $0.01. The business had revenue of $8.89 million for the quarter, compared to the consensus estimate of $7.92 million.
View Itamar Medical's earnings history
.

What price target have analysts set for ITMR?

5 Wall Street analysts have issued 1 year price targets for Itamar Medical's shares. Their forecasts range from $22.00 to $30.00. On average, they expect Itamar Medical's stock price to reach $26.55 in the next twelve months. This suggests a possible upside of 25.4% from the stock's current price.
View analysts' price targets for Itamar Medical
.

Are investors shorting Itamar Medical?

Itamar Medical saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 422,200 shares, an increase of 43.8% from the August 15th total of 293,600 shares. Based on an average daily trading volume, of 26,400 shares, the short-interest ratio is currently 16.0 days.
View Itamar Medical's Short Interest
.

Who are some of Itamar Medical's key competitors?

What other stocks do shareholders of Itamar Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Itamar Medical investors own include Gilead Sciences (GILD), AbbVie (ABBV), Carnival (CCL), Energy Transfer LP Unit (ET), KeyCorp (KEY), Occidental Petroleum (OXY), Pfizer (PFE), Primo Water (PRMW), Wells Fargo & Company (WFC) and Abbott Laboratories (ABT).

Who are Itamar Medical's key executives?

Itamar Medical's management team includes the following people:
  • Mr. Gilad Glick, Pres, CEO and Acting VP of Marketing & Sales (Age 47, Pay $561k)
  • Mr. Shy Basson, CFO & COO of U.S. (Age 48, Pay $397k)
  • Mr. Itay Kariv, VP of R&D and Technology (Age 61, Pay $243k)
  • Mr. Eilon Livne, VP of Sales & Channels Devel. EMEA (Age 49, Pay $209k)
  • Prof. Peretz Lavie, Founder

What is Itamar Medical's stock symbol?

Itamar Medical trades on the NASDAQ under the ticker symbol "ITMR."

Who are Itamar Medical's major shareholders?

Itamar Medical's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Calamos Advisors LLC (1.41%), Russell Investments Group Ltd. (1.37%), Roubaix Capital LLC (0.26%), Schonfeld Strategic Advisors LLC (0.19%) and Jane Street Group LLC (0.16%).

Which institutional investors are selling Itamar Medical stock?

ITMR stock was sold by a variety of institutional investors in the last quarter, including Calamos Advisors LLC.

Which institutional investors are buying Itamar Medical stock?

ITMR stock was purchased by a variety of institutional investors in the last quarter, including Roubaix Capital LLC, Schonfeld Strategic Advisors LLC, Russell Investments Group Ltd., and Jane Street Group LLC.

How do I buy shares of Itamar Medical?

Shares of ITMR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Itamar Medical's stock price today?

One share of ITMR stock can currently be purchased for approximately $21.18.

How big of a company is Itamar Medical?

Itamar Medical has a market capitalization of $236.71 million and generates $31.26 million in revenue each year. Itamar Medical employs 184 workers across the globe.

This page was last updated on 9/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.